Yahoo Finance Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
Michael Sturmer, President at Progyny Inc (NASDAQ:PGNY), sold 6,395 shares of the company on April 1, 2024, according to a recent SEC filing. The transaction was executed at an average price of $37.6 per share, resulting in a total value of $240,442.
Progyny Inc (NASDAQ:PGNY) is a company that specializes in fertility and family building benefits solutions in the United States. The company offers employer-sponsored fertility benefits for employees and their partners who are seeking to start a family. Progyny's services include access to a premier network of fertility specialists, treatment management, pharmacy benefits, and other related services.
Over the past year, Michael Sturmer has sold a total of 34,141 shares of Progyny Inc and has not made any purchases of the stock. The insider transaction history for Progyny Inc shows a pattern of 42 insider sells and no insider buys over the past year.
As of the date of the insider's recent transaction, Progyny Inc (NASDAQ:PGNY) had a market cap of $3.449 billion. The stock's price-earnings ratio stood at 57.66, which is above the industry median of 24.26 but below the company's historical median price-earnings ratio.
The stock was trading at $37.6 on the day of the transaction, with a GuruFocus Value of $68.83. This indicates a price-to-GF-Value ratio of 0.55, suggesting that Progyny Inc (NASDAQ:PGNY) is significantly undervalued based on its GF Value.
The GF Value is calculated considering historical trading multiples, a GuruFocus adjustment factor based on the company's past returns and growth, and future business performance estimates provided by Morningstar analysts.
The insider trend image above reflects the recent selling activity by insiders at Progyny Inc (NASDAQ:PGNY).
The GF Value image provides a visual representation of the stock's current valuation in relation to its intrinsic value estimate.
For more detailed information on insider transactions and stock performance, investors and analysts are encouraged to visit the SEC filing and the company's profile on GuruFocus.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
